Mammary gland density predicts the cancer inhibitory activity of the N-3 to N-6 ratio of dietary fat

Cancer Prevention Research

Volumn 4, Issue 10, 2011, Pages 1675-1685

  Zhu, Zongjian ^a   Jiang, Weiqin ^a   McGinley, John N ^a   Prokopczyk, Bogden ^b   Richie Jr , John P ^b   El Bayoumy, Karam ^b   Manni, Andrea ^b   Thompson, Henry J ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LEPTIN; METHYLNITROSOUREA; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SOMATOMEDIN C; TAMOXIFEN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT INTAKE; FEMALE; GAS CHROMATOGRAPHY; MAMMARY GLAND; NONHUMAN; PRIORITY JOURNAL; RAT;

ADIPOSE TISSUE; ALKYLATING AGENTS; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CYTOKINES; DIET; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; INSULIN-LIKE GROWTH FACTOR I; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; RATS; RATS, SPRAGUE-DAWLEY; TAMOXIFEN;

EID: 80053908006     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0175     Document Type: Article

References (60)

1. Calviello G, Serini S. Dietary omega-3 polyunsaturated fatty acids and cancer. New York: Springer; 2010.
2. Engeset D, Alsaker E, Lund E, Welch A, Khaw KT, Clavel-Chapelon F, et al. Fish consumption and breast cancer risk. The European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2006;119:175-82.
3. MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, Suttorp MJ, et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 2006;295:403-15. (Pubitemid 43144977)
4. Brasky TM, Lampe JW, Potter JD, Patterson RE, White E. Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol Biomarkers Prev 2010;19: 1696-708.
5. Witt PM, Christensen JH, Schmidt EB, Dethlefsen C, Tjønneland A, Overvad K, et al. Marine n-3 polyunsaturated fatty acids in adipose tissue and breast cancer risk: a case-cohort study from Denmark. Cancer Causes Control 2009;20:1715-1.
6. Thiébaut AC, Chajès V, Gerber M, Boutron-Ruault MC, Joulin V, Lenoir G, et al. Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. Int J Cancer 2009;124:924-31.
7. Carroll KK. Dietary fat in relation to mammary carcinogenesis. Princess Takamatsu Symp 1985;16:255-3.
8. Hopkins GJ, Kennedy TG, Carroll KK. Polyunsaturated fatty acids as promoters of mammary carcinogenesis induced in Sprague-Dawley rats by 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 1981;66:517-2.
9. Abou-el-Ela SH, Prasse KW, Carroll R, Wade AE, Dharwadkar S, Bunce OR, et al. Eicosanoid synthesis in 7,12-dimethylbenz(a)anthracene- induced mammary carcinomas in Sprague-Dawley rats fed primrose oil, menhaden oil or corn oil diet. Lipids 1988;23:948-4.
10. Abou-el-Ela SH, Prasse KW, Farrell RL, Carroll RW, Wade AE, Bunce OR, et al. Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets. Cancer Res 1989;49:1434-0.
11. Chatterjee M, Janarthan M, Manivannan R, Rana A, Chatterjee M. Combinatorial effect of fish oil (Maxepa) and 1alpha,25-dihydroxyvitamin D(3) in the chemoprevention of DMBA-induced mammary carcinogenesis in rats. Chem Biol Interact 2010;188:102-10.
12. Craig-Schmidt M, White MT, Teer P, Johnson J, Lane HW. Menhaden, coconut, and corn oils and mammary tumor incidence in BALB/c virgin female mice treated with DMBA. Nutr Cancer 1993;20:99-106. (Pubitemid 23270878)
13. Karmali RA, Donner A, Gobel S, Shimamura T. Effect of n-3 and n-6 fatty acids on 7,12 dimethylbenz (a) anthracene-induced mammary tumorigenesis. Anticancer Res 1989;9:1161-7.
14. Manna S, Chakraborty T, Damodaran S, Samanta K, Rana B, Chatterjee M, et al. Protective role of fish oil (Maxepa) on early events of rat mammary carcinogenesis by modulation of DNA-protein crosslinks, cell proliferation and p53 expression. Cancer Cell Int 2007;7:6.
15. Manna S, Chakraborty T, Ghosh B, Chatterjee M, Panda A, Srivastava S, et al. Dietary fish oil associated with increased apoptosis and modulated expression of Bax and Bcl-2 during 7,12-dimethylbenz (alpha)anthracene-induced mammary carcinogenesis in rats. Prostaglandins Leukot Essent Fatty Acids 2008;79:5-4.
16. Gentile MG, Pastorelli P, Ciceri R, Manna GM, Collimedaglia S. Fish oil regulates cell proliferation, protect DNA damages and decrease HER- 2/neu and c-Myc protein expression in rat mammary carcinogenesis. Clin Nutr 2010;29:531-7.
17. Minami M, Noguchi M. Effects of low-dose eicosapentaenoic acid, docosahexaenoic acid and dietary fat on the incidence, growth and cell kinetics of mammary carcinomas in rats. Oncology 1996;53:398-405. (Pubitemid 26283783)
18. Noguchi M, Minami M, Yagasaki R, Kinoshita K, Earashi M, Kitagawa H, et al. Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA. Br J Cancer 1997;75:348-3.
19. Chlebowski RT, Blackburn GL. Diet and breast cancer recurrence. JAMA 2007;298:2135-6.
20. Prentice RL, Thomson CA, Caan B, Hubbell FA, Anderson GL, Beresford SA, et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst 2007;99:1534-43. (Pubitemid 351767234)
21. Rohan TE, Negassa A, Caan B, Chlebowski RT, Curb JD, Ginsberg M, et al. Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial. Cancer Prev Res 2008;1:275-84.
22. U.S.Department of Health and Human Services. Dietary guidelines for Americans. www.healthierus.gov/dietaryguidelines: U.S. Department of Agriculture; 2005.
23. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356:227-36. (Pubitemid 46143226)
24. Stone J, Ding J, Warren RM, Duffy SW, Hopper JL. Using mammographic density to predict breast cancer risk: dense area or percentage dense area. Breast Cancer Res 2010;12:R97.
25. Conroy SM, Woolcott CG, Koga KR, Byrne C, Nagata C, Ursin G, et al. Mammographic density and risk of breast cancer by adiposity: An analysis of four case-control studies. Int J Cancer 2011; May 31. [Epub ahead of print].
26. Goodwin PJ. Host-related factors in breast cancer: an underappreciated piece of the puzzle? J Clin Oncol 2008;26:3299-300.
27. Chapkin RS, McMurray DN, Davidson LA, Patil BS, Fan YY, Lupton JR, et al. Bioactive dietary long-chain fatty acids: emerging mechanisms of action. Br J Nutr 2008;100:1152-7.
28. Thompson HJ, McGinley JN, Rothhammer K, Singh M. Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis 1995;16: 2407-11.
29. Thompson HJ, Singh M, McGinley J. Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1-nitrosourea. J Mammary Gland Biol Neoplasia 2000;5:201-10. (Pubitemid 32045696)
30. Singh M, McGinley JN, Thompson HJ. A comparison of the histopathology of premalignant and malignant mammary gland lesions induced in sexually immature rats with those occurring in the human. Lab Invest 2000;80:221-31. (Pubitemid 30120974)
31. McGinley JN, Thompson HJ. Quantitative assessment of mammary gland density in rodents using digital image analysis. Biol Proced Online 2011;13:4.
32. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986;27:114-20. (Pubitemid 16045295)
33. Sokal RR, Rohlf FJ. Biometry the principles and practice of statistics in biological research. 3rd ed. New York: W.H. Freeman; 1995.
34. Snedecor GW, Cochran WG. Statistical methods. 8th ed. Ames, IA: Iowa State University Press; 1989.
35. Harrell FE. Regression modeling strategies. New York: Springer- Verlag; 2001.
36. Manni A, Xu H, Washington S, Aliaga C, Cooper T, Richie JP, et al. The impact of fish oil on the chemopreventive efficacy of tamoxifen against development of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis. Cancer Prev Res 2010;3:322-30.
37. Zhu Z, Haegele AD, Thompson HJ. Effect of caloric restriction on premalignant and malignant stages of mammary carcinogenesis. Carcinogenesis 1997;18:1007-12. (Pubitemid 28132347)
38. Wei N, Wang B, Zhang QY, Mi MT, Zhu JD, Yu XP, et al. Effects of different dietary fatty acids on the fatty acid compositions and the expression of lipid metabolic-related genes in mammary tumor tissues of rats. Nutr Cancer 2008;60:810-25.
39. Wolf I, O'Kelly J, Rubinek T, Tong M, Nguyen A, Lin BT, et al. 15- hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. Cancer Res 2006;66:7818-23. (Pubitemid 44289243)
40. Huang G, Eisenberg R, Yan M, Monti S, Lawrence E, Fu P, et al. 15- Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer. Cancer Res 2008;68:5040-8.
41. Myung SJ, Rerko RM, Yan M, Platzer P, Guda K, Dotson A, et al. 15- Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proc Natl Acad Sci U S A 2006;103:12098-102. (Pubitemid 44215817)
42. Yan M, Myung SJ, Fink SP, Lawrence E, Lutterbaugh J, Yang P, et al. 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors. Proc Natl Acad Sci U S A 2009;106:9409-13.
43. Yan M, Rerko RM, Platzer P, Dawson D, Willis J, Tong M, et al. 15- Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers. Proc Natl Acad Sci U S A 2004;101:17468-73. (Pubitemid 39657428)
44. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 2009;27:3437-44.
45. Grossmann ME, Ray A, Nkhata KJ, Malakhov DA, Rogozina OP, Dogan S, et al. Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev 2010; 29:641-53.
46. Ray A, Cleary MP. Leptin as a potential therapeutic target for breast cancer prevention and treatment. Expert Opin Ther Targets 2010; 14:443-51.
47. Vona-Davis L, Rose DP. Angiogenesis, adipokines and breast cancer. Cytokine Growth Factor Rev 2009;20:193-201.
48. Cleary MP, Ray A, Rogozina OP, Dogan S, Grossmann ME. Targeting the adiponectin:leptin ratio for postmenopausal breast cancer prevention. Front Biosci (Schol Ed) 2009;1:329-57.
49. Vona-Davis L, Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 2007;14:189-206. (Pubitemid 47242622)
50. Brown KA, Hunger NI, Docanto M, Simpson ER. Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase. Breast Cancer Res Treat 2010;123:591-6.
51. Brown KA, Simpson ER. Obesity and breast cancer: progress to understanding the relationship. Cancer Res 2010;70:4-7.
52. Martin de Santa OL, Sanchez Muniz FJ, Vaquero MP. N-3 fatty acids in glucose metabolism and insulin sensitivity. Nutr Hosp 2009;24:113-27.
53. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary longchain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 2004;79:935-45. (Pubitemid 41095944)
54. Prince MJ, Deeg MA. Do n-3 fatty acids improve glucose tolerance and lipemia in diabetics? Curr Opin Lipidol 1997;8:7-11. (Pubitemid 27148501)
55. Vessby B. n-3 fatty acids and blood glucose control in diabetes mellitus. J Intern Med Suppl 1989;731:207-10. (Pubitemid 19191769)
56. Kalaany NY, Sabatini DM. Tumours with PI3K activation are resistant to dietary restriction. Nature 2009;458:725-31.
57. Ghayad SE, Cohen PA. Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients. Recent Pat Anticancer Drug Discov 2010;5:29-57.
58. Perks CM, Holly JM. IGF binding proteins (IGFBPs) and regulation of breast cancer biology. J Mammary Gland Biol Neoplasia 2008; 13:455-69.
59. Dillon RL, White DE, Muller WJ. The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer. Oncogene 2007;26:1338-45. (Pubitemid 46328463)
60. Cully M, You H, Levine AJ, Mak TW. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 2006;6:184-92. (Pubitemid 43292562)